EUA
Rapid SARS-CoV-2 Antigen Test Card
FDA Emergency Use Authorization · Xiamen Boson Biotech Co., Ltd. · Jan 23, 2024
Key facts
| Product | Rapid SARS-CoV-2 Antigen Test Card |
|---|---|
| Company | Xiamen Boson Biotech Co., Ltd. |
| Product type | Lateral Flow, Visual Read, Over the Counter (OTC) Home Testing, Serial Testing, Serial Screening, Single Target |
| Date | Jan 23, 2024 |
| FDA page | fda.gov |
At a glance
- 10–99 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: